A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
Recruiting
Observational Study
Artificial Intelligence (AI)
Artificial Intelligence (AI) in Diagnosis
Cardiovascular Diseases (CVD)
Echocardiography
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,600 (estimated)
- Sponsor
- First Hospital of China Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This project aims to collaborate with multiple medical institutions to verify the accuracy, stability, and clinical application value of AI algorithms in echocardiographic quantitative measurement through multi-center clinical research. Specific objectives include:
1. Compare the automatic measurement results of AI with the manual measurement data from physicians of different levels, and analyze …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age ≥18 - 80 years;
2. Types of diseases (8 in total, 200 cases each):
1. Normal heart
2. Coronary heart disease (with segmental thinning and abnormal movement)
3. Valve disease (valve stenosis or reflux)
4. Hypertensive heart disease
5. Atrial fibrillation
…
Contacts
Chunyan Ma the First Hospital of China Medical Univeristy, Ph.D
13998816448
CONTACT